Chronic Lymphocytic Leukemia (CLL): Treatment Updates

Listen Now

Topics Covered

• Review of Chronic Lymphocytic Leukemia (CLL), in the Context of COVID-19 & Its Variants
• Significant Role of Testing in Informing Your Treatment Choices
• First Line Treatment Options
• Treatment of Relapsed & Refractory CLL
• Re-Testing Importance in Determining Treatment for 2nd & 3rd Line Treatments
• Current Perspectives on New & Emerging Treatments of CLL
• Updates on Clinical Trials & Their Significance for CLL
• Guidelines to Prepare for Telehealth/Telemedicine Appointments, including Technology, Prepared List of Questions, Follow-Up Appointments & Discussion of OpenNotes
• Practical Support to Cope with CLL
• Questions for Our Panel of Experts

Our Panel of Experts

Mazyar Shadman, MD, MPH

Associate Professor, Clinical Research Division, Fred Hutchinson Cancer Research Center, Associate Professor, Medical Oncology Division, University of Washington, Associate Professor, Attending Physician, Seattle Cancer Care Alliance

Adam S. Kittai, MD

Assistant Professor, Division of Hematology, Department of Internal Medicine, The Ohio State University Wexner Medical Center

Patricia Koffman

Co-Founder, CLL Society Inc.

Carolyn Messner, DSW, BCD, FAPOS, FAOSW

Senior Director of Education and Training, CancerCare

Brochure

You can download the brochure for this workshop

Workshop Date

This workshop was originally recorded on September 08, 2022.